Oxford Lane Capital (OXLC) Q1 2027 earnings summary

Executive summary

• Net asset value per share increased to $10.74 as of June 30, 2026, up from $10.56 in the prior quarter.

• GAAP net investment income was $50.2 million ($0.51/share), down from $54.5 million ($0.56/share) in the previous quarter.

• Core net investment income was $93.4 million ($0.95/share), compared to $100.7 million ($1.03/share) last quarter.

• Portfolio primarily consists of CLO equity (99.6% of fair value), diversified across over 287 positions as of June 30, 2026.

• Top industry exposures include high tech, finance, business services, and healthcare, representing nearly 100% of combined investments.

Financial highlights

• Net unrealized appreciation of $54.5 million and net realized losses of $28.4 million recorded.

• Net increase in net assets from operations was $76.3 million ($0.78/share).

• Weighted average effective yield on CLO equity investments declined to 11.1% from 11.7% sequentially.

• Weighted average cash distribution yield on CLO equity investments decreased to 16.3% from 16.7%.

• $37.8 million in new CLO investments made; $50.7 million received from sales and repayments.

Outlook and guidance

• Board declared monthly common stock distributions of $0.20/share for October, November, and December 2026.

• Preferred share dividends declared for Series 2029 and 2031 at fixed annual rates of 6.00%, 7.125%, and 8.25%.

• Over half of the investment book has short-term optionality for resets or refinancings through 2027.

• Management remains focused on opportunistic CLO investment strategy to maximize long-term total return.

• CLO equity expected to make initial distributions by 3/31/27 totals $65.2 million at original cost.